Vasopressors vs Inotropes: An EDAIC Haemodynamic Case
Use an original shock case to distinguish pressure, flow and perfusion, then interpret vasopressor and inotrope choices with current sepsis guidance.

A vasopressor principally aims to support arterial pressure through effects that include vascular tone. An inotrope aims to increase myocardial contractility. Individual medicines can have several actions, so the categories describe a major therapeutic purpose rather than perfectly separate boxes.
For EDAIC, keep pressure, flow and tissue perfusion distinct. A higher blood pressure is an important observation, but it does not automatically prove that every organ is receiving adequate flow or that the underlying shock has resolved.
Start with a simplified relationship
For revision, mean arterial pressure minus right atrial pressure is approximately related to cardiac output multiplied by systemic vascular resistance, with consistent units. This is a useful organising relationship, not a complete model of the circulation.
Imagine two hypothetical states in arbitrary, consistent units:
- State A: flow 5 and resistance 14 give a pressure difference of 70.
- State B: flow 3.5 and resistance 20 also give a pressure difference of 70.
The identical product hides different flow and resistance. This arithmetic example does not diagnose a patient, but it demonstrates why a pressure value alone cannot identify the underlying haemodynamic state.
Now reverse the question. If pressure rises after a treatment, which term changed, and what happened to the others? Without additional observations, the honest answer is that the pressure response alone does not tell you the full story.
Try 10 EDAIC questions free
Create a free account and answer EDAIC-style Part 1 MTF questions — each one graded per statement, with a full explanation.
Original case: pressure improves, uncertainty remains
An adult with septic shock receives initial treatment. Arterial pressure improves with a vasopressor, but there are continuing signs that raise concern about perfusion. The examiner supplies evidence of cardiac dysfunction and asks whether the blood-pressure response means treatment is complete.
A structured response would reassess the diagnosis, volume status, cardiac function, perfusion and the adequacy of the measurements. It would not automatically add an inotrope simply because a laboratory value remains abnormal, nor dismiss the problem because pressure has improved.
The 2026 Surviving Sepsis Campaign guideline suggests inotropic therapy when cardiac dysfunction and persistent hypoperfusion remain despite adequate fluid status and arterial pressure. It describes adding dobutamine to norepinephrine or using epinephrine in that context, with very low-certainty evidence. The conditions and uncertainty are part of the recommendation.
Compare aims before comparing names
| Question | Reasoning focus |
|---|---|
| Is arterial pressure inadequate? | Why pressure is low and whether vascular support is needed |
| Is cardiac performance impaired? | Evidence of dysfunction and its contribution to flow |
| Does hypoperfusion persist? | Multiple observations and their trajectory, not one isolated label |
| What did the intervention change? | Pressure, flow, rhythm, perfusion and adverse effects |
| What remains untreated? | The cause of shock and any additional physiological problem |
This table deliberately avoids giving a universal drug sequence. The same medicine may have a different balance of effects according to the patient's physiology and treatment context. A receptor list helps explain possible actions; it does not replace observation of the actual response.
For revision, write a drug's intended benefit beside its possible trade-off. Then ask what you would monitor to determine which effect predominates in the hypothetical case. That produces a stronger answer than reciting a receptor mnemonic and stopping.
What current sepsis guidance does—and does not—say
The 2026 guideline maintains a prominent role for norepinephrine and provides context-specific recommendations for additional agents and concomitant cardiac dysfunction. Its inotrope discussion specifies that patients needing vasopressors to maintain the pressure target may need inotropes in addition to, rather than instead of, that support.
Do not turn this into a rule that all shock is septic shock, that every low output needs the same drug, or that an inotrope should be continued regardless of response. Those conclusions exceed the clinical situation described by the guideline.
For a useful study exercise, remove “septic” from the vignette and identify which parts of the argument must now be reconsidered. You will see that a treatment recommendation has a population and diagnosis attached to it.
Answer an EDAIC-style question
This is one exam-format Part 1 multiple-true-false question from our bank. Mark each statement true or false, then see the worked answer.
Regarding the pathophysiology of oxygen delivery and consumption in circulatory shock:
Mark each statement true or false:
In healthy adults at rest, systemic oxygen delivery is approximately 1000 mL/min while oxygen consumption is about 250 mL/min, creating a physiological oxygen reserve.
When systemic oxygen delivery decreases, oxygen consumption immediately falls in direct proportion, indicating supply dependency at all levels of DO₂.
Cardiac output is determined by the product of heart rate and stroke volume, with stroke volume being influenced by preload, afterload, and myocardial contractility.
The unifying feature of all forms of shock, regardless of aetiology, is acute circulatory failure associated with inadequate cellular oxygen utilisation.
In septic shock, early goal-directed therapy targeting supranormal oxygen delivery values has been shown to consistently reduce mortality across all patient populations.
An older trial still teaches an important reading skill
The SOAP II trial compared dopamine and norepinephrine in patients with shock. Its primary overall 28-day mortality comparison was not statistically significant, while arrhythmias were more frequent with dopamine. A cardiogenic-shock subgroup finding should be recognised as a subgroup result, rather than silently substituted for the trial's overall primary outcome.
This is a practical example of why a paper can influence drug selection without supporting the simplified claim “drug A proved lower mortality in everyone”. Benefit, adverse effects, the primary endpoint and subgroup analyses answer different questions.
Use the confidence-interval guide to review that distinction. The oxygen-content and delivery examples help connect circulation to oxygen transport, and the arterial-line guide reminds you that the pressure measurement itself deserves scrutiny.
Close the loop with reassessment
In the original case, suppose pressure rises again but tachyarrhythmia develops. Calling the response an unqualified success would ignore a new problem. Suppose instead that measured flow improves while the presumed perfusion marker remains abnormal. That discrepancy deserves interpretation and a time course, not a reflex assumption that one measurement must be wrong.
The habit to practise is explicit: state the intended endpoint, name the potential harm and explain how you will judge the response. It keeps pharmacology attached to clinical reasoning.
Three statements to judge
“Equal arterial pressures imply equal cardiac outputs.” False. Different combinations of flow and resistance can produce the same pressure difference.
“An inotrope can make pressure support unnecessary in every patient.” False. Contractility and vascular support address different aspects of the circulation.
“A trial with a non-significant primary mortality comparison contains no useful evidence.” False. Other prespecified outcomes and adverse effects can be informative, provided their interpretation remains accurate.
Use the AnesCORE question bank to practise linking each drug statement to an aim, a mechanism and a measurable consequence.
Sources
- SCCM/ESICM: Surviving Sepsis Campaign adult guidelines 2026
- De Backer et al: dopamine versus norepinephrine in shock, SOAP II
Prepared with AI assistance for examination revision; sources checked 6 November 2026. These original teaching examples are not official EDAIC questions. Not a patient-care protocol.
Start preparing for EDAIC Part I
Syllabus-mapped lessons, 30,000 MTF questions, spaced-repetition flashcards and an AI study plan — in one platform.
Start free